Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. No substantive changes to study content or eligibility criteria are indicated.
    Difference
    0.0%
    Check dated 2026-03-12T00:29:33.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed a government funding lapse notice alongside the prior Revision: v3.4.1; these are site maintenance/version updates and do not affect study content, eligibility criteria, or results pages. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:35:16.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding notice banner and updated the page revision to v3.4.1, replacing the previous v3.4.0 revision.
    Difference
    0.4%
    Check dated 2026-02-04T10:40:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Glossary is now displayed and QC-related metadata (Last Update Submitted that Met QC Criteria) and revision version (v3.4.0) have been added, while the older QC label, No FEAR Act data, and Revision: v3.3.4 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:39:35.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:58:51.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section listing California, Georgia, and Nebraska as study sites.
    Difference
    0.4%
    Check dated 2025-12-23T21:55:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.